Abstract
Matrix metalloproteinases (MMPs) are a family of zinc and calcium‐dependent endopeptidases involved in remodeling and physiological homeostasis of extracellular matrix (ECM). The metalloproteinases activity is predominantly modulated by specific tissue inhibitors of matrix metalloproteinases (TIMPs). The balance between MMPs and TIMPs is likely to play an important role in remodeling uterine arteries in pregnancy, and it may represent means by which vasodilatation is maintained in later pregnancy. Moreover, increased levels of MMPs and in particular MMP‐2 play a role in the vascular alterations induced by hypertension. The aim of this study was the evaluation of MMP‐2 and ‐9, along with their inhibitors TIMP‐1 and ‐2, in pre‐eclamptic women compared with normotensive pregnancy and non‐pregnant women. Fourteen pre‐eclamptic women were compared with 37 normotensive women in different gestational age and 21 non‐pregnant women. Multiplexed sandwich enzyme‐linked immunosorbent assay was used to measure MMPs and TIMPs simultaneously. MMP‐2 levels were significantly higher in pre‐eclamptic women vs. both non‐pregnant and physiologic pregnant women. MMP‐9 concentrations were significantly higher in physiologic pregnant vs. non‐pregnant women. The serum levels of TIMP‐1 were significantly higher in pre‐eclamptic vs. both non‐pregnant and physiologic pregnant women. TIMP‐2 values were higher in physiologic pregnant women and pre‐eclamptic women vs. non‐pregnant women. A positive correlation between MMP‐9 values and gestational age was observed in normal pregnant women. Results of the present investigation confirm that MMP‐2 and TIMP‐1 values are significantly higher in preeclampsia. We confirm that the modification of the fine balance between MMPs and their inhibitors plays a greater role in the structural and functional vascular changes of women with complicated pregnancies. J. Clin. Lab. Anal. 23:88–92, 2009. © 2009 Wiley‐Liss, Inc.
Keywords: metalloproteinases, preeclampsia, pregnancy
REFERENCES
- 1. Mott JD, Werb Z. Regulation of matrix biology by matrix metalloproteinases. Curr Opin Cell Biol 2004;16:558–564. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2. Tayebjee MH, Lip GY, Blann AD, Macfadyen RJ. Effects of age, gender, ethnicity, diurnal variation and exercise on circulating levels of matrix metalloproteinases (MMP)‐2 and ‐9, and their inhibitors, tissue inhibitors of matrix metalloproteinases (TIMP)‐1 and ‐2. Thromb Res 2005;115:205–210. [DOI] [PubMed] [Google Scholar]
- 3. Schoenhagen P, Vince DG, Ziada KM, et al. Relation of matrix‐metalloproteinase 3 found in coronary lesion samples retrieved by directional coronary atherectomy to intravascular ultrasound observations on coronary remodeling. Am J Cardiol 2002;89:1354–1359. [DOI] [PubMed] [Google Scholar]
- 4. Sternlicht MD, Werb Z. How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 2001;17:463–516. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. McCawley LJ, Matrisian LM. Matrix metalloproteinases: They're not just for matrix anymore! Curr Opin Cell Biol 2001;13:534–540. [DOI] [PubMed] [Google Scholar]
- 6. Greene J, Wang M, Liu YE, Raymond LA, Rosen C, Shi YE. Molecular cloning and characterization of human tissue inhibitor of metalloproteinase 4. J Biol Chem 1996;271:30375–30380. [DOI] [PubMed] [Google Scholar]
- 7. Chen L, Belton RJ Jr, Nowak RA. Basigin‐mediated gene expression changes in mouse uterine stromal cells during implantation. Endocrinology Oct 1 [Epub ahead of print]. 2008. [DOI] [PMC free article] [PubMed]
- 8. Merchant SJ, Davidge ST. The role of matrix metalloproteinases in vascular function: Implications for normal pregnancy and pre‐eclampsia. BJOG 2004;111:931–939. [DOI] [PubMed] [Google Scholar]
- 9. American College of Obstetrics and Gynecology . Hypertension in Pregnancy. Washington, DC: The College; ACOG Technical Bulletin No. 219, 1996. [Google Scholar]
- 10. Popek EJ. Normal anatomy and histology of the placenta In: Lewis SH, Perrin EZ, editors. Pathology of the Placenta, second edition Philadelphia: Churchill Livingstone, 1999. p 49–88. [Google Scholar]
- 11. Kelly BA, Bond BC, Poston L. Gestational profile of matrix metalloproteinases in rat uterine artery. Mol Hum Reprod 2003;9:351–358. [DOI] [PubMed] [Google Scholar]
- 12. Liotta LA, Steeg PS, Stetler‐Stevenson WG. Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation. Cell 1991;64:327–336. [DOI] [PubMed] [Google Scholar]
- 13. Huang HY. The cytokine network during embryo implantation. Chang Gung Med J 2006;29:25–36. [PubMed] [Google Scholar]
- 14. Shibahara H, Suzuki T, Kikuchi K, Hirano Y, Suzuki M. Serum matrix metalloproteinase and tissue inhibitor of metalloproteinase concentrations in infertile women achieved pregnancy following IVF‐ET. Am J Reprod Immunol 2005;54:186–192. [DOI] [PubMed] [Google Scholar]
- 15. Myers JE, Merchant SJ, Macleod M, Mires GJ, Baker PN, Davidge ST. MMP‐2 levels are elevated in the plasma of women who subsequently develop preeclampsia. Hypertens Pregnancy 2005;24:103–115. [DOI] [PubMed] [Google Scholar]
- 16. Narumiya H, Zhang Y, Fernandez‐Patron C, Guilbert LJ, Davidge ST. Matrix metalloproteinase‐2 is elevated in the plasma of women with preeclampsia. Hypertens Pregnancy 2001;20:185–194. [DOI] [PubMed] [Google Scholar]
- 17. Kim WU, Min SY, Cho ML, et al. Elevated matrix metalloproteinase‐9 in patients with systemic sclerosis. Arthritis Res Ther 2005;7:R71–R79. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. Maymon E, Romero R, Pacora P, et al. A role for the 72kDa gelatinase (MMP‐2) and its inhibitor (TIMP‐2) in human parturition, premature rupture of membranes and intraamniotic infection. J Perinat Med 2001;29:308–316. [DOI] [PubMed] [Google Scholar]
- 19. Kolben M, Lopens A, Bläser J, et al. Proteases and their inhibitors are indicative in gestational disease. Eur J Obstet Gynecol Reprod Biol 1996;68:59–65. [DOI] [PubMed] [Google Scholar]
- 20. Hurst PR, Palmay RD. Matrix metalloproteinases and their endogenous inhibitors during the implantation period in the rat uterus. Reprod Fertil Dev 1999;11:395–402. [DOI] [PubMed] [Google Scholar]
- 21. Okamoto T, Niu R, Yamada S, Osawa M. Reduced expression of tissue inhibitor of metalloproteinase (TIMP)‐2 in gestational trophoblastic diseases. Mol Hum Reprod 2002;8:392–398. [DOI] [PubMed] [Google Scholar]
- 22. Merchant SJ, Narumiya H, Zhang Y, Guilbert LJ, Davidge ST. The effects of pre‐eclampsia and oxygen environment on endothelial release of matrix metalloproteinase‐2. Hypertens Pregnancy 2004;23:47–60. [DOI] [PubMed] [Google Scholar]
- 23. Lindsay MM, Maxwell P, Dunn FG. TIMP‐1: A marker of left ventricular diastolic dysfunction and fibrosis in hypertension. Hypertension 2002;40:136–141. [DOI] [PubMed] [Google Scholar]